Janus Henderson Group’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $384K | Hold |
27,472
| – | – | ﹤0.01% | 2075 |
|
|
2025
Q1 | $397K | Hold |
27,472
| – | – | ﹤0.01% | 2073 |
|
|
2024
Q4 | $526K | Hold |
27,472
| – | – | ﹤0.01% | 2006 |
|
|
2024
Q3 | $625K | Hold |
27,472
| – | – | ﹤0.01% | 1924 |
|
|
2024
Q2 | $357K | Buy |
27,472
+14,051
| +105% | +$183K | ﹤0.01% | 2126 |
|
|
2024
Q1 | $235K | Buy |
13,421
+57
| +0.4% | +$997 | ﹤0.01% | 2344 |
|
|
2023
Q4 | $291K | Sell |
13,364
-31
| -0.2% | -$675 | ﹤0.01% | 2249 |
|
|
2023
Q3 | $206K | Buy |
13,395
+9
| +0.1% | +$138 | ﹤0.01% | 2371 |
|
|
2023
Q2 | $318K | Sell |
13,386
-28
| -0.2% | -$666 | ﹤0.01% | 2218 |
|
|
2023
Q1 | $341K | Buy |
+13,414
| New | +$341K | ﹤0.01% | 2222 |
|